Skip to main content
Fig. 1 | BMC Rheumatology

Fig. 1

From: A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases

Fig. 1

Results of bivariate analysis to assess the factors associated with the risk of COVID-19 infection. Significant values in Multivariate analysis; Gender (p = 0.001), DM (p = 0.001), Lung disease (p < 0.001), Glucocorticoid (7.5-20 mg) (p = 0.04), CYC (p < 0.001), Rituximab (p = 0.003). Abbreviations RA rheumatoid arthritis, SLE systemic lupus erythematosus, DM diabetes mellitus, HTN hypertension, CYC cyclophosphamide, TNFi tumor necrosis factor alpha inhibitor, HCQ hydroxychloroquine, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us